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 Galactokinase (EC 2.7.1.6) phosphorylates galactose to
form galactose-1-phosphate, allowing its conversion to UDP-
galactose, from which it can be isomerized to UDP-glucose
or incorporated into glycolipids and glycoproteins.
Galactokinase deficiency is an autosomal recessive disorder
(OMIM 230200) characterized by hypergalactosemia and the
primary clinical manifestation of cataract formation at birth
or in the first few months of life. In galactosemia, while some
galactose is oxidized to galactonate, most of it is reduced by
aldose reductase to form galactitol, which accumulates in the
lens with subsequent hyperosmotic disruption of lens fiber
cells. Heterozygous galactokinase deficiency has been reported
to be significantly increased in Caucasian patients developing
bilateral idiopathic cataract between 20 and 55 years of age,
especially in the presence of a high galactose diet [1]. The
incidence of heterozygous galactokinase deficiency has been
estimated to be approximately 1 in 309 in Caucasians by en-
zyme activity, corresponding to an allele frequency of approxi-
mately 3x10-6 [2]. The human galactokinase gene (GALK1),
cloned in 1995 and mapped to chromosome 17q24, consists
of 8 exons and 7 introns and encodes a protein of 392 amino
acids [3]. All known galactokinases share three highly con-
served regions containing a galactokinase signature sequence
(exon 1) and two separate ATP binding motifs (exons 3 and
7). A total of 24 mutations in GALK1 resulting in galactokinase
deficiency have been described so far [3-7]. Most of these
mutations are confined to individual families, but some have
been observed in individuals of Costa Rican/European descent
(Q382X) and of eastern European origin (Bosnian, Romani
Gypsies, P28T).
Four mutations have been identified only in Japanese in-
dividuals [4] and the A198V mutation, known as the Osaka
variant, has been reported to show an allele frequency of 4.1%
in a sample of 291 Japanese controls, and to be associated in
homozygotes with an 80% reduction of Galk activity [8]. The
Osaka variant was found in the same study to have an allele
frequency of 2.8% in Koreans but to be rare in other Asian
populations and absent in Caucasians. In a group of 148 Japa-
nese patients over 55 years of age and undergoing surgery for
age-related cataract, the frequency of the mutation was found
to be significantly increased (7.8%, P<0.023) compared to that
in the controls and 2 homozygous and 19 heterozygous indi-
viduals were identified [8]. Taken together with the results of
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Purpose: To investigate possible associations between sequence changes in the galactokinase gene (GALK1) and age-
related cataract in a European population.
Methods: Persons without lens opacities and persons with clinically significant age-related cataract were selected from
those participating in the Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cata-
ract or from those attending the Section of Ophthalmology of the University of Parma for cataract surgery. Type and
severity of the opacities were assessed by slit-lamp and retro-illumination lens photographs. Mutations in GALK1 were
identified by PCR amplification of individual exons and flanking sequences and sequencing using fluorescent terminator
technology in an ABI 377 Prism or 3100 automated DNA sequencer.
Results: DNA samples were obtained from 115 individuals with clear lenses and from 185 individuals with cataract (106
with any nuclear, 88 with any cortical, and 25 with any posterior sub capsular cataract). 157 of the 185 patients with
cataract (85%) were age-matched with a control within an age range of plus or minus 1 year. SNPs causing amino acid
changes in the galactokinase protein were identified in exon 4; I184M, 1/115 control versus 0/185 cataractous individuals,
p=0.38, exon 6; G274D, 0/115 control versus 1/185 cataractous individuals, p>0.99, and exon 7; V338A, 0/115 control
versus 1/185 cataractous individuals, p>0.99. Thus, there were no significant differences in the distribution of sequence
alterations resulting in amino acid changes between control and cataractous individuals. Eighty samples showed a C to T
transition 43 bases into intron 7 (46 cataracts and 34 controls). Testing the distribution of the intron 7 findings showed
Hardy-Weinberg equilibrium for both cases (p=0.73) and controls (p=0.51). There was no difference in C/T distribution
between cases and controls (p=0.27).
Conclusions: In this northern Italian population age-related cataract does not appear to be associated with GALK1 alleles.
Since this is due to a lack of sequence changes in both affected and control individuals, this study cannot rule out the
possibility of an association in other populations.
Correspondence to: Giovanni Maraini, M.D., Ophthalmology, Uni-
versity of Parma Via Gramsci 14 43100 Parma, Italy Phone: +39-
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Stambolian, et al. [1] associating heterozygous GALK1 defi-
ciency with presenile cataract, these data suggested that as yet
uncharacterized GALK1 alleles resulting in mild deficiency
might contribute to age-related cataract in European popula-
tions. In this study we investigated the occurrence of muta-
tions in GALK1 from 185 individuals with age-related cata-
ract and 115 age-matched controls with clear lenses in a North-
ern Italian population.
METHODS
Subjects:  We included in the study a total of 300 individuals,
185 with age-related cataract and 115 with clear lenses. Most
subjects (135 of those with cataract, 73%; and 115 of the con-
trols, 100%) were participants in the Collaborative Italian-
American Clinical Trial of Nutritional Supplements and Age-
related Cataract (CTNS). Fifty subjects (27%) of the cataract
group were patients admitted to the Institute of Ophthalmol-
ogy of the University of Parma for age-related cataract sur-
gery. CTNS is an ongoing, National Eye Institute supported,
thirteen year study whose primary objective is to evaluate the
safety and efficacy of a vitamin-mineral supplement contain-
ing recommended daily allowance (RDA) dosages in prevent-
ing age-related cataract or delaying its progression.
In CTNS lens status is assessed twice at baseline and then
at each annual visit by grading slit-lamp and retro-illumina-
tion lens photographs according to a modification of the Age-
Related Eye Disease Study (AREDS) lens opacities grading
system [9]. A revised scale for nuclear opalescence was adopted
after densitometric evaluation of the slit-lamp standard pho-
tographs suggested that the introduction of an additional stan-
dard between original standards 5 and 6 would improve scor-
ing. Nuclear severity grade is therefore assigned on a scale
defined by 8 standards with decimal grades ranging from 0.9
to 8.1. Both cortical and posterior sub-capsular opacities are
graded on retro-illumination photographs by dividing the pu-
pillary area into 17 sub-fields by superimposing the photo-
graph to be graded on a grid of concentric circles with eight
radiating spokes. Estimates of each sub-field weighted by area
are combined to calculate the percent involvement of the cen-
tral 5 mm circle and the entire visible area of the lens. The
same photographic technique and grading system were uti-
lized for the non-CTNS patients with age-related cataract in-
cluded in this study.
In this study a person was classified as having clear lenses
if both eyes had a grade <3.0 for nuclear opalescence (N),
<5% within the 5 mm circle for cortex (C), and <0.5% within
the 5 mm circle for posterior subcapsular opacities (PSC). A
participant was designated as having a clinically significant
cataract if at least one eye had a severity grade >5.0 for N,
and/or >25% involvement in the central 5 mm circle for C,
and/or >25% involvement outside the 5 mm circle, and/or
>12.5% involvement in the central 5 mm circle for PSC. Early
cataracts were therefore not included in this study, leaving a
free interval between completely clear lenses and clinically
significant types of cataract. A cataract was identified as pure
if only one type of opacity had a severity grade sufficient to
qualify as a clinically significant opacity, and the severity of
the other types of opacity, if present, was compatible with a
definition of no opacity. All other types were classified as
mixed cataracts.
Eligible persons were systematically selected from the
CTNS cohort or from those attending the Institute of Ophthal-
mology for cataract surgery on the basis of the last available
lens severity photographic grading score which, in most cases,
was performed not more than 6 months before blood drawing
for the study. All participants signed a written informed con-
sent form agreeing to participate in the ancillary genetics study.
The ancillary study was approved by the CTNS DSMC and
by the University of Parma and National Eye Institute IRBs
and adhered to the tenets of the Declaration of Helsinki.
Genomic DNA extraction and sequencing:  Human blood
samples (18 ml) were collected in citrate anticoagulated tubes
and frozen at -80 °C. Genomic DNA was isolated using a stan-
dardized protocol that included cell lysis with anionic deter-
gent, high salt precipitation of proteins, ethanol precipitation
to concentrate DNA followed by further purification of DNA
with a buffered phenol/chloroform mixture[10]. After a final
precipitation with alcohol the DNA pellet was dissolved in
TE (Tris-EDTA 10 mM, pH 8.0).
Individual exons of GALK1 were amplified by the PCR
as described by Stambolian, et al. [3]. PCR products were ana-
lyzed on 1% agarose gels and purified using a Quick Step 2,
96 well PCR purification kit (Edge Biosystems, Gaithersburg,
MD) and concentrated by ethanol precipitation. Sequencing
in the forward and reverse directions using the same exon spe-
cific primers as were used for PCR amplification was per-
formed using an Amplitaq FS cycle sequencing kit (ABI, Fos-
ter City, CA) with dye-labeled terminators according to the
manufacturer’s instructions. Sequencing reactions were puri-
fied using Performa DTR 96 well short plat kit (Edge
Biosystems, Gaithersburg, MD) and sequences were analyzed
on an ABI 3100 DNA analysis system (ABI).
Statistical analysis:  The frequencies of sequence changes
in the case and control groups were compared using Fisher’s
exact test. Hardy-Weinberg equilibrium of the sequence change
in intron 7 was assessed by comparing the observed and ex-
pected C-T pair frequencies by Fisher’s exact test. The Breslow
test of homogeneity was applied to test whether the C-T pair
distributions of the case and control groups were equal. All
statistical analysis was performed with Statistical Analysis
System (SAS) software.
RESULTS & DISCUSSION
 The distribution of participants by lens status, age, and other
factors are shown in Table 1. Of the 185 patients with cataract
who participated in the study, 106 had a nuclear cataract (79
pure form, 74.5%), 88 had a cortical cataract (66 pure form,
75%), and 26 had a posterior sub-capsular cataract (7 pure
form, 26.9%). 27 patients with N cataract had a mixed type of
opacity (11PN, 14 CN, 2 CPN), 22 patients with C cataract
had a mixed type of opacity (14 CN, 6 CP, 2 CPN), and 19
patients with P cataract had a mixed type of opacity (11 PN, 6
CP, 2 CPN). The mean age of controls was 68 years (range 59
to 78 yrs) and the mean age of cataracts was 71 years (range
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50 to 80 yrs). 157 of the 185 patients with cataract (85%) were
age-matched with a control within an age range of plus or
minus 1 year (the same participant with clear lenses could act
as control for patients with different types of opacities).
Eight single nucleotide polymorphisms (SNPs) were iden-
tified in the exons of GALK1 and their flanking intronic se-
quences (Table 2). Three coding SNPs resulted in amino acid
changes in 3 individuals; 615C->G (I184M) in 1 individual
without cataracts, 884G->A (G274D) in 1 individual with cor-
tical cataracts, and 1076T->C (V338A) in one individual with
nuclear cataracts. In addition, there were three coding SNPs
not resulting in amino acid changes; 252G->A (L63L) in 1
patient with nuclear cataracts, 315G->A (E84E) in 1 individual
with cortical cataracts, and 1119G->A (T352T) in 1 individual
with mixed nuclear and posterior subcapsular cataracts. Fi-
nally, two intronic SNPs were detected. The first was a G to A
change 34 bases into intron 4 in two individuals, one with a
nuclear cataract and one control individual. The second was a
frequent polymorphic change, C to T 43 bases into intron 7,
which was seen in 80 individuals, 76 heterozygous (44 cata-
ractous and 32 control individuals) and 4 homozygous (2 cata-
ractous and 2 control individuals). As can be seen from Table
2, none of these changes showed a statistically significant as-
sociation with cataracts, nor did they show significant asso-
ciation in their aggregate. The results were not different if
analyzed only for the 157 age-matched cases. The intron 7
SNP was in Hardy-Weinberg equilibrium in both cataract and
control groups, and was distributed evenly between them.
GALK1 was a logical candidate gene for age-related cata-
ract as suggested by a number of observations; (a) complete
GALK1 deficiency results in galactosemia with congenital
cataracts [11], (b) some GALK1 alleles resulting in partial de-
ficiency are associated with presenile cataracts in the pres-
ence of a diet rich in galactose [1], and (c) the Osaka (A198V)
variant, with about 20% of residual activity due to a shorter
half life, appears to contribute to a significant fraction of age
related cataracts in Japanese [8]. The Osaka variant was also
found in Koreans as well as some Chinese, although not, so
far, in European or African populations. The Osaka variant
was not present in the Northern Italians studied here, either
among cataractous or control individuals. Neither were any of
the alleles that were found associated with age-related cata-
ract, although the GALK1 activity of these allelic variants was
not determined. The upper 95% confidence limit on the oc-
currence of any of these sequence changes among these cata-
ract patients doesn’t exceed 3.0%. This rarity excludes GALK1
sequence changes as a significant cause of age-related cata-
ract in this population.
The original design was a case-control study with case-
control pairs matched on age. Following Schlesselman’s
sample size formula for the McNemar test analysis, it was
determined that for a minimum power of 80% with two-sided
0.05 level testing, 100 pairs would be adequate to detect rela-
tive risks of from 4 (assuming a 5% mutation prevalence in
controls) to 10 (assuming a 1% prevalence in controls). In the
course of the study the difficulty in recruiting older controls
led to the abandonment of pair matching in favor of an age-
adjustment in the analysis stage. At study’s end, the observed
prevalences were much lower than assumed at the outset.
Consequently the post hoc power for detecting odds ratios even
as high as 10.0, by Fisher’s exact test, was negligible (less
than 1%) for all except the Intron 7 comparison, which, al-
though not significant, was capable of detecting a two-fold
increase in odds with 80% power.
It should be noted that the lack of association seen in this
population was likely due to the paucity of allelic variants
detected, and thus does not in any way speak to the ability of
the Osaka or other allelic variants of GALK1 to contribute to
cataracts when present. The study population is a fairly ho-
mogeneous Northern Italian population and these results may
be extrapolated to some degree to other European populations,
but certainly not to African or Asian population groups. How-
ever, in this Northern Italian population, specific GALK1 alle-
les do not appear to be associated with age-related cataract.
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TABLE 1. DISTRIBUTION OF PARTICIPANTS BY LENS STATUS, AGE, AND
OTHER FACTORS
                       Nuclear      Cortical         PSC          Controls
                      opacities     opacities     opacities    (clear lenses)
                      ----------   -----------   -----------   --------------
Total number of          106           88            26             115
  lenses
Pure cataracts            79           66             7
Mixed cataracts           27           22            19
Mean severity score   5.6 (0.6)    43.3 (20.3)   32.0 (19.9)
  (pure type SD)
Median age (range)    72 (50-80)   71 (59-79)    68 (61-77)      69 (59-78)
Female                  46.2%         52.3%         44.0%          40.0%
Hypertension          22 (20.7%)   22 (25.0%)    11 (42.3%)      17 (14.8%)
Diabetes               7  (6.6%)   10 (11.4%)     7 (26.9%)       6  (5.2%)
Smoking (ever)        58 (54.7%)   32 (36.4%)     9 (34.6%)      60 (52.2%)
Myopia >10 D           1  (0.9%)    0  (0%)       1  (3.8%)       0  (0%)
IOP >21                1  (0.9%)    2  (2.2%)     2  (7.6%)       0  (0%)
Some individuals with mixed cataract types are counted in more than
one category. The condition titled “Hypertension” indicates anti-hy-
pertensive therapy or systolic >170 and/or diastolic >95.
TABLE 2. DISTRIBUTION OF GALK1 GENE SEQUENCE CHANGES AND
ASSOCIATED AMINO ACID CHANGES AMONG CATARACTOUS AND CONTROL
INDIVIDUALS.
  Exon/                    Codon
 intron         SNP        change   Cataracts   Controls   p value
---------   ------------   ------   ---------   --------   -------
Exon 2       c.252G->A      L63L       1(N)         0       >0.99
(56-118)     c.315G->A      E84E       1(C)         0       >0.99
Exon 4       c.615C->G     I184M       0            1        0.38
(159-203)
Intron 4     IVS4+34G->A               1(N)         1       >0.99
Exon 6       c.884G->A     G274D       1(C)         0       >0.99
(264-314)
Exon 7       c.1076T->C    V338A       1(N)         0       >0.99
(315-368)    c.1119G->A    T352T       1(PN)        0       >0.99
Intron 7    IVS7+43C->T               48           36        0.27
            SNP rs743554
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